KATHRYN BOBBITT: Open Payments
NPI 1225899396 · TYLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,417 in 36 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $935 · 2025 $1,417
Food & beverage: $1,037Travel & lodging: $380
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 16 | $942 |
| Merck Sharp & Dohme LLC | 5 | $102 |
| Novo Nordisk Inc | 1 | $98 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $80 |
| Novartis Pharmaceuticals Corporation | 4 | $79 |
| AstraZeneca Pharmaceuticals LP | 3 | $58 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
| Alnylam Pharmaceuticals Inc. | 1 | $16 |
Products named: CARDIOMEMS, VERQUVO, Wegovy, LifeVest, LEQVIO, Kerendia, LOKELMA, CAMZYOS.
Industry payments across TX — which companies pay providers there.
